睡眠特征的血浆蛋白质组学揭示全身免疫代谢通路及遗传优先蛋白质
基于英国生物银行43709名中老年参与者,本研究绘制了七种自报睡眠特征及睡眠健康评分的血浆蛋白质组图谱,鉴定出935种与至少一种睡眠特征相关的蛋白质,并发现LTA对夜间睡眠充足性有推定因果效应,遗传支持的候选蛋白质与多种疾病风险相关。
要点
- 935种血浆蛋白质与至少一种睡眠特征相关,涉及脂代谢、免疫炎症等通路。
- 遗传支持的候选蛋白质与心血管病、糖尿病、痴呆、抑郁等发病风险相关。
核心结论
- 大规模血浆蛋白质组学可揭示睡眠特征的生物学通路,并生成可验证的因果假设。
研究设计与样本
- 基于英国生物银行43709名 predominantly 欧洲 ancestry 中老年参与者的观察性蛋白质组关联研究,结合基因组结构方程模型和双向孟德尔随机化。
主要发现
- 鉴定出935种蛋白质与至少一种睡眠特征相关,汇聚于脂代谢、免疫功能与炎症、细胞黏附和神经化学信号。
- LTA对夜间睡眠充足性有推定因果效应,具有稳健的顺式工具和强共定位支持(PP.H4=0.98)。
- 遗传支持的候选蛋白质前瞻性关联于 incident 心血管疾病、卒中、2型糖尿病、痴呆、慢性肾病、抑郁和死亡,中位随访13.6年。
- 每标准差风险比最强的关联见于慢性肾病(如BTN2A1:HR=2.33)和2型糖尿病(如RBP5:HR=1.58)。
关键数值与推荐
- LTA对夜间睡眠充足性的推定因果效应共定位支持PP.H4=0.98。
- 慢性肾病关联BTN2A1的每标准差HR=2.33。
- 2型糖尿病关联RBP5的每标准差HR=1.58。
临床怎么用
- 提示睡眠障碍可能与免疫代谢通路相关,为精神心理科评估睡眠问题时提供潜在的生物学标志物研究方向。
- 遗传支持的蛋白质候选可用于构建睡眠相关躯体共病(如心血管病、糖尿病、抑郁)的风险分层假设。
局限性
- 参与者主要为欧洲 ancestry 中老年人,结果外推需谨慎。
- 睡眠特征为自报数据,存在测量偏差。
- 除LTA外,多数遗传支持的候选蛋白质证据较弱,需独立队列和实验模型验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The plasma proteomic signatures of sleep disturbance remain poorly characterized. Using data from 43,709 predominantly European-ancestry, middle-aged and older UK Biobank participants, we depict a large-scale atlas of plasma proteomic signatures of seven self-reported sleep traits (sleep duration, chronotype, insomnia symptoms, daytime napping, daytime sleepiness, snoring, and ease of getting up in the morning) and a derived sleep health score. We identify 935 proteins associated with at least one sleep trait, converging on lipid metabolism, immune function and inflammation, cell adhesion, and neurochemical signaling. Leveraging genomic structural equation modeling to define three latent sleep factors, namely circadian preference, daytime sleep burden, and nighttime sleep adequacy, bidirectional Mendelian randomization (MR) identifies one protein (LTA) with robust cis-instrument and strong colocalization support (PP.H4 = 0.98) for a putative causal effect on nighttime sleep adequacy. Sixteen additional genetically supported candidate proteins rely primarily on trans-pQTL instruments or weaker colocalization. These genetically supported candidates are prospectively associated with incident cardiovascular disease, stroke, type 2 diabetes, dementia, chronic kidney disease, depression, and mortality over a median 13.6-year follow-up, with the strongest per-SD hazard ratio (HR) associations observed for chronic kidney disease (e.g., BTN2A1: HR = 2.33) and type 2 diabetes (e.g., RBP5: HR = 1.58). Collectively, these findings highlight the potential of large-scale proteomics in elucidating sleep pathogenesis, and generate testable hypotheses for validation in independent cohorts and experimental models.
引用
- Chen H, Wang X, Chen W, et al. Plasma proteomics of sleep traits reveals systemic immune-metabolic pathways and genetically prioritized proteins. Mol Psychiatry. 2026. PMID: 42277229. doi:10.1038/s41380-026-03678-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。